Skip to content

Cerebrolysin 60mg

♢ Research use only Klassespecificatie; geselecteerde partijen Janoshik-getest

Gehaltebepaling Content quantification (Janoshik)Cerebrolysin 60mg · Report #212145 ↗

€28.99

Free standard EU shipping on orders over €200

If a product doesn't match the specification on its published COA, contact us with your batch number: we investigate against the lot's report and replace any product that fails it, at no cost to you.

Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

Returns policy →
Shipping estimate for EU

3–7 days most of the EU · 10–14 Nordics/Baltics. Dispatched within 1–2 business days. Check destination rates at checkout.

Full shipping information

Cerebrolysin van onderzoekskwaliteit. Vastgelegde specificatie: peptidehydrolysaat (extract van varkenshersenen), ≥85% peptiden ≤10 kDa; geselecteerde partijen onafhankelijk getest. Gelyofiliseerd poeder in verzegelde glazen flacon. Uitsluitend voor onderzoeksdoeleinden. Niet bestemd voor menselijke consumptie.

Over Cerebrolysin 60mg

Cerebrolysin is a multi-peptide brain-derived neurotrophic preparation consisting of enzymatically treated porcine brain protein. The preparation contains a mixture of low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier. It has an unusually long history for a peptide complex and has been studied in the context of neurological injury models including ischemic, traumatic, and vascular insults — and has been characterised since the 1970s. Each vial contains 60mg of the lyophilized preparation.

The active components of Cerebrolysin are not fully defined chemically, which distinguishes it from single-compound neurotrophic peptides. The preparation has demonstrated neurotrophic factor-like activity in cell culture and animal models: it promotes neuronal survival, enhances synaptic plasticity, stimulates neurogenesis, and exhibits neuroprotective effects in various injury models. Preclinical and in-vitro studies have examined its effects on recovery and cognitive parameters in injury and neurodegeneration models, with variable results across study designs. The European Medicines Agency has characterised it within some neurological research contexts.

For research purposes, Cerebrolysin is a useful tool for studying multi-factor neurotrophic support — where the combined effect of multiple small peptides may recapitulate some of the biological activity of endogenous neurotrophic factors (BDNF, NGF, GDNF) more completely than any single defined compound.

Specifications

Parameter Value
Compound Cerebrolysin (porcine brain-derived neuropeptide complex)
Amount per Vial 60mg lyophilized
Composition Low-MW neuropeptides + free amino acids from porcine brain proteins
Format Lyophilized powder
Reconstitution Sterile water or saline
Opslag 2-8°C

Opslag

Store at 2-8°C (refrigerator) as lyophilized powder. Refrigerate after reconstitution. As a biological preparation, avoid freezing and thawing cycles.

What makes Cerebrolysin different from a single neurotrophic peptide?

Single neurotrophic peptides (like BDNF or NGF) target specific receptors. Cerebrolysin contains a mixture of multiple small peptides and amino acids that together mimic aspects of the brain’s complex neurotrophic environment. In research, this can be advantageous when the goal is broad neuroprotection or neurogenesis stimulation rather than receptor-specific pharmacology. The trade-off is that the mixture composition is not fully defined, which limits mechanistic interpretation. Cerebrolysin is better suited for studies where the preparation itself is the research focus, or for generating hypotheses that can then be pursued with defined single compounds.

How does Cerebrolysin penetrate the blood-brain barrier?

Cerebrolysin’s active components are specifically the low-molecular-weight fraction (peptides under approximately 10 kDa) — the preparation is enzymatically processed to ensure these small peptides predominate. Small peptides can cross the blood-brain barrier through passive diffusion (if sufficiently lipophilic), transcytosis, or active transport. The preparation is documented to produce measurable CNS effects after systemic IV or IM administration in preclinical models, indicating at least partial CNS delivery. The full pharmacokinetics of the mixed preparation are complex to characterize precisely.

What are the main research areas for Cerebrolysin?

The most-studied research area for Cerebrolysin is ischemic injury models — preclinical work has examined neurological outcome parameters when administered early in models of ischemic insult. Neurodegeneration models have examined cognitive parameters in some studies but not consistently across designs. Traumatic injury models have been another focus, with preclinical data examining neuroprotection. The research base is heterogeneous in quality, and the compound is characterised differently across regulatory jurisdictions.

Cerebrolysin is supplied for research purposes only. Not for human consumption. Handle in compliance with institutional biosafety guidelines.

Vertrouwen van onderzoekers

Waarom onderzoekers voor CertaPeptides kiezen

Wie test dit eigenlijk?

Geselecteerde partijen worden onafhankelijk geverifieerd door Janoshik Analytical (Tsjechië) en gepubliceerd op het openbare Janoshik-portaal. Andere partijen worden geleverd met de batchspecificatie van de leverancier. Zie /coa voor de gepubliceerde muur.

COA's bekijken →

Wat als ik de verkeerde batch krijg?

Elk flaconlabel draagt een code. Zoek die op via onze verificatiepagina: die toont wat CertaPeptides voor die code publiceert en, bij een teruggetrokken partij, dat de partij is teruggetrokken en waarom. Is uw partij teruggetrokken, of levert de code op uw label niets op, mail ons dan die code.

COA's bekijken →

Vanwaar wordt het verzonden?

Roemenië (EU). Wij zijn CERTALAB SRL, CUI 54169956, btw-geregistreerd. Sameday voor Roemenië, GLS voor de meeste EU-bestemmingen, TCE Worldwide voor de overige grensoverschrijdende EU- en niet-EU-markten (VK, Zwitserland). Bezorging 1–15 werkdagen afhankelijk van de bestemming — exacte termijn getoond bij het afrekenen.

Verzendgegevens →

Wat als er een probleem is?

U heeft een herroepingsrecht van 14 dagen op grond van OUG 34/2014 (Roemeens/EU-consumentenrecht), met mogelijkheid tot escalatie via ANPC en tot alternatieve geschillenbeslechting (SAL). Neem contact met ons op via support@chinapeptideshop.com.

Retourbeleid →

Productinformatie

Dit product is uitsluitend bedoeld voor wetenschappelijk onderzoek en ontwikkeling. Het is een chemische stof die niet mag worden gebruikt als geneesmiddel, medicijn, werkzame stof of ingrediënt in enig product bedoeld voor menselijke of dierlijke consumptie. Onderzoekers dienen deze verbinding te hanteren in overeenstemming met hun institutionele bioveiligheidsrichtlijnen. Gebruik deze uitsluitend in goed uitgeruste laboratoriumomgevingen met geschikte persoonlijke beschermingsmiddelen.

Veelgestelde vragen

Onderzoeksbibliotheek

Gerelateerde onderzoeksartikelen

Alles bekijken

Frequently researched together

Combined Price €157.46

View All Products
Verwijs een onderzoeker

Vertel het een collega-onderzoeker

Geef 15% korting, verdien 10% terug op hun eerste bestelling.

Cerebrolysin 60mgResearch use only
Added to cart

Essential cookies keep your cart and account working. Optional content is disabled until you allow it.

Recently viewed products stay only in this browser for up to 30 days. Turning optional personalization off clears that history.

europa.eu/youreurope/garantie

Customer support

Live chat is not connected yet. Please contact our support team by email.

support@chinapeptideshop.com